Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MEG.0b013e32834f4d19PMID 22246328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improvement of Non-Steroidal Anti-Inflammatory Drug-Induced Gastrointestinal Symptoms during Proton Pump Inhibitor Treatment: Are G-Protein β3 Subunit Genotype, Helicobacter pylori Status, and Environmental Factors Response Modifiers?

  2011cited by this paper
• Clinical practice. Helicobacter pylori infection.

  2010cited by this paper
• National Institute for Health and Clinical Excellence

  2010cited by this paper
• The Gap Between Clinical Trials and Clinical Practice: The Use of Pragmatic Clinical Trials to Inform Regulatory Decision Making

  2010cited by this paper
• Helicobacter pylori infection.

  2009cited by this paper
• Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents

  2008cited by this paper
• Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease

  2007cited by this paper
• Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors

  2006cited by this paper
• Technical review on the evaluation of dyspepsia

  2006cited by this paper
• Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non‐steroidal anti‐inflammatory drugs

  2006cited by this paper
• Improvements with Esomeprazole in Patients with Upper Gastrointestinal Symptoms Taking Non-Steroidal Antiinflammatory Drugs, Including Selective COX-2 Inhibitors

  2005cited by this paper
• Guidelines for the Management of Dyspepsia

  2005cited by this paper
• Inadequate Prevention of NSAID-Induced Gastrointestinal Events

  2004cited by this paper
• Costs and efficacy of three different esomeprazole treatment strategies for long‐term management of gastro‐oesophageal reflux symptoms in primary care

  2004cited by this paper
• Underutilization of preventive strategies in patients receiving NSAIDs.

  2003cited by this paper
• Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.

  2003cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.

  2000cited by this paper
• How Satisfied Are Chronic Heartburn Sufferers with Their Prescription Medications? Results of the Patient Unmet Needs Survey

  2000cited by this paper
• Toxicity of NSAIDs in the stomach and duodenum.

  1999cited by this paper
• Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

  1999cited by this paper
• Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.

  1999cited by this paper
• Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

  1999cited by this paper
• Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

  1999cited by this paper
• Quality of life in arthritis patients using nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• Helicobacter pylori infection and dyspepsia.

  1998cited by this paper
• AGA technical review: evaluation of dyspepsia. American Gastroenterological Association.

  1998cited by this paper
• AGA technical review: Evaluation of dyspepsia ☆ ☆☆

  1998cited by this paper
• Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs

  1998cited by this paper
• Gastric bicarbonate secretion and release of prostaglandin E2 are increased in duodenal ulcer patients but not in Helicobacter pylori-positive healthy subjects.

  1996cited by this paper
• Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.

  1996cited by this paper
• Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper

• Gastrointestinal symptoms in NSAID users in an ‘average risk population’: results of a large population‐based study in randomly selected Dutch inhabitants

  2014cites this paper
• Prevalence and determinants of gastrointestinal symptoms in the Dutch community

  2013cites this paper